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Abstract
Objective: This study aimed to investigate the reliability of diabetic adipose-derived stem cells (ADSCs) for autologous 
cell-based therapies by exploring the functionality of signalling pathways involved in regulating oxidative stress and 
apoptosis. 
Materials and Methods: In this experimental study, ADSCs were isolated from streptozotocin (STZ)-induced diabetic 
rats (dADSCs) and normal rats (nADSCs). The colonies derived from dADSCs and nADSCs were compared by 
colony-forming unit (CFU) assay. Reactive oxygen species (ROS) formation and total antioxidant power (TAP) were 
also measured. Furthermore, the expression of antioxidant enzymes, including catalase (Cat), superoxide dismutase 
(Sod)-1 and -3, glutathione peroxidase (Gpx)-1, -3 and -4 was measured at mRNA level by semi-quantitative reverse 
transcriptase polymerase chain reaction assay. The expression of Bax, Bcl2, caspase-3, total and phosphorylated 
c-Jun N-terminal kinase (JNK) and P38 Mitogen-Activated Protein Kinase (MAPK) at protein level was analyzed by 
western blotting.
Results: The results of this study indicated that viability and plating efficiency of dADSCs were significantly lower than 
those of nADSCs. ROS generation and TAP level were respectively higher and lower in dADSCs. The gene expression 
of antioxidant enzymes, including Cat, Sod-1, Gpx-3 and Gpx-4 in dADSCs was significantly greater than that in 
nADSCs. However, Sod-3 and Gpx-1 mRNA levels were decreased in dADSCs. Moreover, Bax/Bcl-2 protein ratio, 
caspase-3 protein expression and phosphorylation of JNK and P38 proteins were increased in dADSCs compared to 
nADSCs.
Conclusion: Taken together, diabetes might impair the cellular functions of dADSCs as candidates for autologous cell-
based therapies. This impairment seems to be mediated by JNK, P38 MAPKs, and mitochondria pathway of apoptosis 
and partly by disruption of antioxidant capacity. 
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Introduction 
In type 1 diabetes, destruction of beta cells located in 
the pancreas, leads to elevated blood glucose levels and 
pathological changes in different organs (1). Currently, 
insulin therapy is the most common therapeutic strategy 
used for type 1 diabetes. Since, in some cases, insulin 
therapy could not properly control the progression of 
diabetes and its complications (2), other alternative 
therapies might be desirable (3, 4). Modern therapeutic 
approaches not only mitigate the symptoms of the disease 
but also improve organs’ function. Stem cell therapy 
has been proposed as a promising therapeutic strategy 
for a number of degenerative disorders including type 1 
diabetes (5). 
Adipose derived stem cells (ADSCs) exhibit the ability 
to self-renew and differentiate into various functional cell 
types. Moreover, ADSCs have higher availability, require 
minimal invasive harvesting procedure and exert a larger 
yield as compared with other mesenchymal stem cells. 
Therefore, ADSCs are known as suitable candidates for 
cell therapy (6). 
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Oxidative stress is considered to play an important role 
in the development of various diseases including diabetes 
mellitus. Free radicals like superoxide radical (O2-) that 
are abundantly produced under diabetic conditions, may 
hamper the normal function of mesenchymal stem cells 
(7, 8). For example, it was shown that diabetes impeded 
the growth and differentiation ability of bone marrow 
mesenchymal stem cells (BMSCs) (9) and mitigated the 
angiogenic potential of ADSCs (10). In normal situations, 
natural enzymatic and non-enzymatic antioxidant defense 
system protects the body’s organs against free radical 
damage. Free radicals could be eliminated by antioxidant 
enzymes, such as catalase (CAT), superoxide dismutase 
(SOD) and glutathione peroxidase (GPx) (11) which 
were shown to be affected by diabetes (12). There is 
controversial data in the literature regarding the effects 
of diabetes on antioxidant enzymes (13) that may be due 
to differences between organs or experimental conditions 
like the duration of diabetes induction (14, 15). Moreover, 
the involvement of mitogen-activated protein kinases 
(MAPKs) and Bcl-2 family in diabetes progression, was 
shown (16). MAPKs include c-Jun NH2-terminal kinases 
(JNK), P38 and extracellular signal-regulated kinase1/2 
(ERK1/2) and play key roles in cell viability and death 
(17). The Bcl-2 family is engaged with apoptosis and 
survival control, and Bax and Bcl-2 are known as pro- and 
anti-apoptotic proteins, respectively (18). However, the 
effect of diabetes on MAPKs, Bcl-2 family and antioxidant 
enzymes in ADSCs, is still unknown. Therefore, the aim 
of the current study was to investigate diabetes-induced 
impaired mechanisms, in particular those related to 
regulation of oxidative stress and apoptosis, in ADSCs.
Materials and Methods 
Fluorescein isothiocyanate (FITC)-conjugated CD90 
and CD45 antibodies and purified anti-rat antibody to 
CD73 were purchased from BD Biosciences Pharmingen 
(San Diego, CA, USA). FITC-conjugated CD11b antibody 
was bought from GeneTex, Inc. (USA). FITC-conjugated 
CD31 and 44 antibodies were purchased from Serotec 
(Oxford, UK). Bax and Bcl-2 antibodies were bought 
from Abcam (Cambridge, UK). Horseradish peroxidase 
(HRP)-conjugated secondary antibody, caspase-3, 
β-actin, c-Jun N-terminal kinase (JNK), P38, Phospho- 
JNK and P38 antibodies were obtained from Cell 
Signaling (Danvers, MA, USA). 2, 4, 6-tri (2-pyridyl)-s-
triazine (TPTZ) was bought from Merck (Germany) and 
3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium 
bromide (MTT), streptozotocin (STZ), collagenase type 
I and 2, 7-dichlorofluorescein diacetate (DCF-DA) were 
bought from Sigma (Sigma Aldrich, St. Louis, MO, 
USA).  All cell culture materials were obtained from 
Gibco (Carlsbad, CA, USA). 
Animals, study design and induction of diabetes
In this experimental study, young male Wistar rats (200-
250 g) were obtained from Pasteur Institute, Tehran, Iran 
and kept at room temperature (22 ± 2 ̊ C) with humidity of 
45-55% and 12:12 hours light-dark cycle. The experiment 
was conducted in accordance with the guidelines of the 
Ethics Committee of  Iran University of Medical Sciences, 
based on National Institutes of Health Principles of 
Laboratory Animal Care (NIH Publications No. 8023, 
revised 1978). Two equal groups were randomly selected 
from 20 male Wistar rats. Control group was injected 
with a single intra-peritoneal injection of normal saline as 
solvent of STZ. Diabetic group was injected with a single 
intra-peritoneal injection of STZ (55 mg/kg) dissolved in 
normal saline. Blood glucose level was monitored 7 days 
later. Only rats with blood glucose levels of >300 mg/dl 
were considered diabetic and kept for four months. During 
this period, blood glucose levels were measured monthly. 
Levels of haemoglobin A1C (HbA1c) were tested in rats 
before being euthanized and only rats with an HbA1c≥ 
6.5 were included. 
Isolation and culture of adipose-derived stem cells
Rats were euthanized using ketamine/xylazine overdose 
and then, adipose tissues were obtained from epididymal 
fat pads of rats. Adipose tissues were minced, washed 
extensively in PBS (Sigma Aldrich, St. Louis, MO, USA) 
containing 5% antibiotic (100 U/ml penicillin and 100 µg 
/ml streptomycin) and digested using 0.075% collagenase 
I (prepared in PBS) at 37˚C for 30 minutes. After adding 
α-modified Eagle’s medium (α-MEM), containing 10% 
fetal bovine serum (FBS, Gibco, Carlsbad, CA, USA) to 
neutralize collagenase, cell suspension was centrifuged 
at 2000 rpm for 10 minutes and the supernatant was 
discarded. Pellet was washed with PBS and filtered 
using 100 µm nylon mesh. Then, filtered fraction was 
centrifuged at 2000 rpm for 10 minutes and the pellet was 
incubated at 37˚C in 5% CO2 with 95% humidity in the 
growth medium (α-MEM with 20% FBS and 100 U/ml 
penicillin and 100 µg /ml streptomycin). After 72 hours, 
non-adherent cells were removed and the growth medium 
was changed every 72 hours. All ADSCs used in this 
study, were from passage 3-4 (10).
Characterizations of adipose-derived stem cells 
To characterize the phenotypes of the isolated ADSCs, 
the cultured ADSCs were harvested and stained with 
antibodies against CD44, CD73, CD90, CD45, CD11b 
and CD31. Cell phenotyping was performed using flow 
cytometry analysis by a FACS caliber cytometer (Becton 
Dickinson, San Diego, CA, USA).
Colony-forming unit assay 
To compare the number of nADSCs- and dADSCs-
derived colonies, CFU test was performed. Briefly, cells 
at early passages were cultured in 6-well plates. Two 
weeks later, all wells were washed with PBS and 5 ml of 
crystal violet solution (0.5% prepared in methanol) was 
added. After 30 min, wells were washed with PBS, and 
the numbers of colonies with a minimum of 50 cells were 
assessed using NIH Image J software (http://rsbweb.nih.
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gov/ij). Then, plating efficiency was calculated according 
to the following formula: 
Plating efficiency=The number of colony /number of cells 
plated×100.
MTT and propidium iodide assay 
Propidium iodide (PI) staining and MTT assays 
were used to assess apoptosis and cell prolifration rate, 
respectively. dADSCs and nADSCs cells were seeded 
in 96-well plates. After 24, 48 and 72 hours, cells were 
exposed to MTT dye for 4 hours. Subsequently, the media 
were discarded, and dimethyl sulfoxide (DMSO) was 
added. The absorbance was measured at 570 nm using a 
micro-plate reader. Cell proliferation rate was measured 
as percentage of control. In PI method, the cells were 
harvested and fixed in ethanol (70%) on ice for 4 hours. 
The cells were treated with RNase and incubated with PI 
staining solution. The stained cells were analyzed by flow 
cytometry (Becton and Dickinson Co., USA) (7). 
Measurement of intracellular reactive oxygen species
DCFH-DA is a lipophilic compound that can pass 
through the plasma membrane. Intracellular ROS oxidizes 
non-fluorescent DCF-DA to the highly fluorescent 
2′-7′-dichlorofluorescein (DCF). Briefly, nADSCs and 
dADSCs were harvested in 24-well plates for 72 hours. 
After discarding media and rinsing cells with PBS, 
ADSCs were incubated with DCF-DA for 30 minutes. For 
the last time, cells were washed with PBS and medium 
was added. Then, the absorbance of DCF was assessed 
at 485/20 (nm) excitation and 528/20 (nm) emission 
wavelength using a multi-detection microplate reader. 
Measurement of total antioxidant power
In this assay, reduction of ferric tripyridyltriazine to 
a blue ferrous complex by samples, is considered an 
indicator of TAP. At first, 290 μl of fresh working solution 
(25 ml acetate buffer (300 mM), 2.5 ml TPTZ (2, 4, 6 
tripyridyl-s-triazine) solution (10 mM in 40 mM HCl), 
and 2.5 ml FeCl3.6H2O) was added to 10 μl of cells 
supernatants. The mixture was incubated at 37˚C for 10 
minutes and the absorbance of the blue complex between 
Fe2+ and TPTZ, was read at 593 nm (Bio-Tek ELX800, 
USA) (19).
Western blot analysis 
Firstly, dADSCs and nADSCs were exposed to 1X 
RIPA lysis buffer that contained 10 µl protease and 
phosphatase inhibitor cocktail. The resultant mixture was 
centrifuged for 20 min at 15,000 g at 4˚C. Total protein 
concentration was determined by Bradford method (20). 
The supernatant was stored at -80˚C. Equal amount of 
samples (70 µg) was separated on 10-12% sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
gel. The proteins were transferred to a polyvinylidene 
fluoride (PVDF) membrane. It was followed by incubation 
with primary antibodies overnight at 4˚C and then, HRP-
labeled secondary antibody for 1 hour. An enhanced 
chemiluminescence kit (Amersham Pharmacia Biotech, 
NJ, USA) was used to visualize the protein bands. β-actin 
was used as the internal control. Then, band density was 
quantified by total Lab software (UK) (21).
Semi-quantitative reverse transcriptase polymerase 
chain reaction 
Total RNA was extracted from the nADSCs and 
dADSCs using RNX-PLUS kit (Cinnagen, Iran) 
according to the manufacturer’s instructions. 
Afterwards, cDNA was synthesized using RNA (1 µg), 
oligo-dT primer (2 µg, Fermentase, USA) and MMLV 
(200 U, Fermentase, USA) in a total volume of 20 µl. 
Reaction was done at 42oC for 1 hour, and continued 
at 72oC for 10 minutes. Finally, polymerase chain 
reaction (PCR) reaction was done using cDNA (5 µl) 
and specific primers (Table 1). β-actin was used as the 
internal control. Final products were run on agarose 
gels (2%) and stained with Nancy-250. Then, band 
was quantified by total lab software (UK).
Table 1: Primers used for semi-quantitative reverse transcriptase 
polymerase chain reaction 
Gene Primer sequence (5ˊ-3ˊ)  Product size
(bp)
Cat F: GGTAACTGGGACCTTGTGGG 222 
R: GCCATTCATGTGCCGATGTC
Sod1 F: AAGCGGTGAACCAGTTGTGG 187 
R: ATTGCCCAGGTCTCCAACAT
Sod3 F: GCTTGTCAGGTGTGGAACC 172 
R: CAGGTCTTTGGAGTGCGTG
Gpx1 F: ACCGTGTATGCCTTCTCC 221 
R: TTGCCATTCTCCTGATGTCC
Gpx3 F: ACCATCTGTGCTCACGGTTT 187 
R: GAAGGAGGTGGTGGCATAG
Gpx4 F: GGAGCCCCAGGTGATAGAG 137 
R: CTGGTTTTCAGGCAGACCGT
β-actin F: TGTCCACCTTCCAGCAGATGT 101
R: AGCTCAGTAACAGTCCGCCTAGA 
Statistical analysis
Data are presented as the mean ± S.E.M. Data were 
analyzed by unpaired student’s t test for comparisons 
between two groups. A P<0.05 was considered statistically 
significant. All data were analyzed by Graphpad Prism 5.0.
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Results
Flow cytometry analysis of CD markers
Phenotype of nADSCs or dADSCs was confirmed 
by flow cytometry analysis. The cell surface markers 
including CD44, CD73 and CD90, were positive while 
CD45, CD11b and CD31 were negative. These results 
indicated that the cultured cells could be considered 
mesenchymal stem cells (Fig.1A). 
Effect of diabetes on plating efficiency of dADSCs and 
nADSCs
CFU assays demonstrated that plating efficiency of 
dADSCs (9 ± 0.57) was remarkably lower than that of 
nADSCs (12.33 ± 0.66, P<0.05, Fig.1B, C).
Fig.1: Identification of ADSCs and assessment of their plating efficiency. A. Flow cytometry analysis showed that surface markers including CD44, CD73 
and CD90 were positive. While CD45, CD11b and CD31 were negative. B. Representative images of colonies derived from nADSCs and dADSCs, obtained 
by light microscopy. C. Assessment of plating efficiency of nADSCs and dADSCs. Results are shown as the mean S.E.M (n=3). *; P<0.05 shows significant 
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Effect of diabetes on cell proliferation rate and 
apoptosis
nADSCs and dADSCs were cultured for 24, 48 and 
72 hours and proliferation rate was measured. As shown 
in Figure 2A, the proliferation rate of dADSCs was 
significantly lower when compared with nADSCs after 
72 hours incubation (P<0.001). To determine the effects 
of diabetes on cell apoptosis, PI staining was conducted. 
As shown in Figure 2B, diabetes pushed cells to commit 
apoptosis. 
Effect of diabetes on intracellular reactive oxygen 
species and total antioxidant power level
As shown in Figure 2C, diabetes significantly increased 
DCF fluorescence as compared with the control group 
(P<0.05). Figure 2D shows that TAP value decreased in 
the diabetic group as compared with the control group 
(P<0.01). 
Effects of diabetes on Bax and Bcl-2 protein levels and 
caspase-3 activation
The protein expression of Bax and Bcl-2 and cleaved 
caspase-3 was measured by western blotting. As shown 
in Figure 3A, the results revealed that Bax/Bcl-2 ratio in 
dADSCs was significantly greater than that in nADSCs 
(P<0.001). Furthermore, as previously shown, active 
form of caspases is produced by proteolytic cleavage 
(22). Hence, we examined cleaved caspase-3 protein 
expression. Results indicated that cleaved caspase-3 
levels markedly increased in dADSCs as compared with 
nADSCs controls (P<0.001, Fig.3B).
Fig.2: Effect of diabetes on proliferation rate, apoptosis and antioxidant status of ADSCs. A. Effect of diabetes on proliferation rate of ADSCs. B. Effect of 
diabetes on apoptosis rate of ADSCs; Sub-G1, G1, S and G2/M phases were separated by gates M1, M2, M3 and M4, respectively. C. ROS formation and D. 
Total antioxidant power. Results are shown as the mean S.E.M (n=3). 
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Fig.3: Effects of diabetes on the Bax/Bcl-2 proteins ratio and cleaved caspase-3 protein. Effects of diabetes on the A. Bax/Bcl-2 proteins ratio, and B. 
Cleaved caspase-3 protein in nADSCs and dADSCs. Results are shown as the mean ± SEM (n=3). 
***; P<0.001 Shows significant differences versus controls, nADSCs; Normal adipose-derived mesenchymal stem cells, and dADSCs; Diabetic adipose-
derived mesenchymal stem cells.
Effects of diabetes on JNK and P38 MAPKs protein 
phosphorylation
Western blotting was performed to determine 
whether dADSCs had different expression of JNK 
and P38 compared to nADSCs controls. Current 
results revealed that phosphorylated JNK and P38 
were significantly increased in dADSCs as compared 
with the controls (P<0.001). Total JNK and P38 
protein levels did not differ between the two groups 
(Fig.4).
Effect of diabetes on mRNA levels of antioxidant 
enzymes
Antioxidant enzymes mRNA levels were measured 
by sqRT-PCR using gene-specific primers (Table 1). A 
significant decrease in Sod-3 (P<0.001) and Gpx-1 (P<0.05) 
mRNA levels was observed in dADSCs as compared with 
the control group. Furthermore, a significant increase in 
Cat (P< 0.001), Sod-1 (P<0. 001), Gpx-3 (P<0.05) and 
Gpx-4 (P<0.001) mRNA levels was detected in dADSCs in 
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Fig.4: Effects of diabetes on phosphorylation of P38 and JNK MAPKs in nADSCs and dADSCs. A. The density of phosphorylated and total P38 were determined and 
the ratio was calculated. B. The density of phosphorylated and total JNK were determined and the ratio was calculated. Results are shown as the mean ± SEM (n=3).
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Fig.5: Effects of diabetes on relative mRNA expression level of antioxidant enzymes. Effects of diabetes on relative mRNA expression level of A. Cat, B. Sod-1, C. 
Sod-3, D. Gpx-1, E. Gpx-3, and F. Gpx-4 in the dADSCs in comparison with the control group. Results are shown as the mean ± SEM (n=3). 
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Discussion
The current study showed that proliferation rate and 
plating efficiency of dADSCs was considerably lower in 
comparison with nADSCs. Furthermore, ROS generation 
and TAP level in dADSCs were respectively higher and 
lower compared to those of nADSCs. The gene expression 
of antioxidant enzymes including Cat, Sod-1, Gpx-3 and 
Gpx-4 was significantly increased in dADSCs as compared 
with nADSCs. In contrast, Sod-3 and Gpx-1 mRNA 
levels were decreased in dADSCs. Bax/Bcl-2 protein 
ratio, cleaved caspase-3 protein and phosphorylation rate 
of JNK and P38 proteins were increased in dADSCs as 
compared with nADSCs. 
Recently, stem cell therapy has been proposed as an 
appropriate alternative approach for treatment of various 
disorders including diabetes. However, diabetes could 
induce many changes at molecular levels in cells including 
stem cells causing serious functional impairment (10). 
Therefore, there is a need to identify intrinsic mechanisms 
disrupted by diabetes. Current study investigated 
the effect of diabetes-induced alterations in ADSCs 
isolated from diabetic rats to elucidate some signalling 
pathways involved in oxidative stress and consequently 
mitochondrial apoptosis. 
Our results indicated that proliferation rate of dADSCs 
was lower than that of non-diabetic controls and 
apoptotic cell death in dADSCs was higher compared to 
nADSCs. This is in agreement with our previous report 
which demonstrated that diabetic stem cells showed 
significantly lower proliferation (10) rate. Furthermore, a 
higher apoptosis rate was shown for diabetic stem cells 
as compared with controls (23). In contrast, there is a 
report indicating similar proliferation rate in dADSCs 
and nADSCs of mice (24). However, differences between 
experimental conditions like duration of diabetes 
induction may cause this discrepancy.  
It was also shown that higher ROS levels in diabetes 
may be linked to cell senescence and death (23). Excess 
production of ROS, an important apoptotic mediator, can 
cause organ injuries (25). Our results showed that ROS 
concentration was elevated in dADSCs. In agreement 
with our findings, a previous study showed that oxidative 
stress leads to impaired self-renewal of adult stem cells in 
vitro (26). 
Under oxidative stress conditions, anti-oxidative 
enzymes such as CAT, SOD, and GPx act as a defense 
barrier against oxidative damages (27). Hydrogen 
peroxide is quickly reduced to superoxide by SOD which 
can be detoxified by activities of GPx and CAT (28). In this 
study, we found that total antioxidant capacity reduced in 
diabetic ADSCs, whereas there were various alterations in 
antioxidants enzyme mRNA expression. This result may 
emphasize the fact that the expressions of some of these 
enzyme have been elevated in response to oxidative stress 
in a compensatory manner to protect against the insult to 
the cells. In agreement with this result, a previous study 
demonstrated that mRNA levels of renal Sod-1, Cat and 
Gpx of diabetic rats enhanced as compared with controls 
(29). In opposite, a previous study performed on diabetic 
heart, showed that total SOD and total GPx expression/
activity were declined whereas CAT expression/activity 
were enhanced (30). Moreover, another study conducted 
on the brain tissue demonstrated a significant decrease in 
mRNA transcription levels of Sod, Cat, and Gpx in the 
diabetic group compared to the controls (31). 
Our results indicated that diabetes affects apoptotic 
pathways in dADSCs. In intrinsic pathway, Bax dimmers 
form mitochondrial membrane pores increase membrane 
permeability allowing the release of pro-apoptotic factors. 
Bcl-2 could form heterodimers with Bax, preventing 
oligomerization and pore assembly in mitochondrial 
membrane (32). Our results revealed that Bax/ Bcl-2 
ratio significantly augmented in dADSCs. In line with 
these results, we previously demonstrated similar results 
indicating that high glucose levels can cause apoptosis 
through elevating Bax/Bcl-2 ratio in PC12 cells (18). 
Another study showed that in BMSCs from patients 
with systemic lupus erythematous, the levels of Bcl-2 
expression were significantly decreased while the Bax 
expression was remarkably increased as compared with 
normal controls (18, 33). As final stage of apoptosis, 
caspase-3 is activated to induce DNA fragmentation and 
cell death (34). Our results demonstrated that diabetes 
could elevate the expression of caspase-3 as an ultimate 
determinant of apoptosis. A former study on PC12 cells 
demonstrated that high glucose levels increased the 
expression of caspase-3, caspase-8 and caspase-9 (35).
In addition to Bcl2 family and caspase, MAPKs 
containing JNK and P38 are important regulators of 
apoptosis. It was indicated that activation of JNK 
and P38 is involved in apoptosis induced by various 
cellular stresses (36). Moreover, it was shown that 
hyperglycemia could activate JNK and p38 in PC12 
neuronal cell (37). Oxidative stress and apoptosis might 
be inhibited by preventing JNK and p38 phosphorylation. 
We demonstrated that p-JNK/JNK and p-P38/P38 were 
increased in dADSCs. This finding is in agreement with a 
previous study demonstrating a higher level of expression 
and activation of JNK and p38 in sural nerve of type I 
and II diabetic patients (38). Taking together, our results 
suggested that dADSCs showed an overall enhancement 
in various apoptotic pathways as compared with the 
controls. It was also suggested that oxidative stress and 
advanced glycation end products (AGES) are major 
factors contributing to alterations in MSCs (39). 
To explain how this impairment could affect cellular 
function and lead to complications in diabetes, it is 
important to realize that, normal MSCs are present in 
various tissues and have the potential to differentiate 
into multiple cell types, playing a central role in 
maintaining tissue homeostasis under both physiological 
and pathological conditions (40). Moreover, it was 
previously shown that autologous ADSCs have the 
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ability to secret many potent angiogenic factors including 
vascular endothelial growth factor (VEGF), fibroblast 
growth factor (FGF), and insulin growth factor-1 (IGF-1) 
and may also play an important role in enhancement of 
angiogenesis and anti-apoptotic ability in diabetes (9, 10). 
Consequently, loss of action or functional impairment 
of dADSCs may be responsible for some of the diabetes 
complications.
Conclusion
It could be concluded that hyperglycemia might 
stimulate oxidative stress, resulting into ADSCs damage. 
Although the current study revealed a significant increase 
in most of mRNA levels of antioxidant enzymes in ADSCs 
from STZ-induced diabetic rats, the total antioxidant 
capacity reduced in these cells. It may be suggested that 
this compensatory response may no longer survive and 
hyperglycemia could induce apoptosis leading to impaired 
cellular functions causing ADSCs death.  It may also be 
concluded that dADSCs may be unsuitable stem cell 
sources for cell therapy and it may also be speculated that 
other diabetes complications may possibly be associated 
with some of these impaired mechanisms.
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